The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Olayioye, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,434
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Early Breast Cancer Trialist's Collaborative Group (1992) · The Lancet · doi:10.1016/0140-6736(92)90997-h · Cited by 2,182
Harvey, J. M., Clark, G. M., Osborne, C. K., & Allred, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1474 · Cited by 2,056
REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY
Tabár, L., Gad, A., Holmberg, L. H., Ljungquist, U., Fagerberg, C. J. G., Baldetorp, L., Gröntoft, O., Lundström, B., Månson, J. C., Eklund, G., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92204-4 · Cited by 1,781
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1996) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.46.1.5 · Cited by 1,759
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
Self-citationFisher, B., Anderson, S., Redmond, C. K., Wolmark, N., Wickerham, D. L., & Cronin, W. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332203 · Cited by 1,465
Easton, D. F., Bishop, D. T., Ford, D., & Crockford, G. P. (1993) · Europe PMC (PubMed Central) · Cited by 1,243
The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling
Hall, J. M., Couse, J. F., & Korach, K. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100029200 · Cited by 1,208
Bonadonna, G., Valagussa, P., Moliterni, A., Zambetti, M., & Brambilla, C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321401 · Cited by 1,049
McCarty, K. S., MILLER, L. S., Cox, E. B., Konrath, J. G., & McCarty, K. S. (1985) · PubMed · Cited by 1,027
Prognostic Factors in Breast Cancer: College of American Pathologists Consensus Statement 1999
Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0966-pfibc · Cited by 1,016
Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials
(1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332202 · Cited by 1,012
(2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.979 · Cited by 893
Bast, R. C., Ravdin, P., Hayes, D. F., Bates, S., Fritsche, H., Jessup, J. M., Kemeny, N., Locker, G. Y., Mennel, R. G., & Somerfield, M. R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1865 · Cited by 879
Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials
(1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341522 · Cited by 783
Radiotherapy after Breast-Preserving Surgery in Women with Localized Cancer of the Breast
Veronesi, U., Luini, A., Del Vecchio, M., Greco, M., Galimberti, V., Merson, M., Rilke, F., Sacchini, V., Saccozzi, R., Savio, T., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282202 · Cited by 751
Proportion of Breast Cancer Cases in the United States Explained by Well-Established Risk Factors
Madigan, M. P., Ziegler, R. G., Benichou, J., Byrne, C., & Hoover, R. N. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.22.1681 · Cited by 655
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
Ross, J. S., Fletcher, J. A., Linette, G. P., Stec, J., Clark, E., Ayers, M., Symmans, W. F., Pusztai, L., & Bloom, K. J. (2003) · The Oncologist · doi:10.1634/theoncologist.8-4-307 · Cited by 610
Look, M. P., van Putten, W. L. J., Duffy, M. J., Harbeck, N., Christensen, I. J., Thomssen, C., Kates, R., Spyratos, F., Ferno, M., Eppenberger-Castori, S., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.2.116 · Cited by 596
Self-citationThe estrogen receptor: a model for molecular medicine.
Jensen, E. V., & Jordan, V. C. (2003) · PubMed · Cited by 573
Intensive Diagnostic Follow-up After Treatment of Primary Breast Cancer: A Randomized Trial
Del Turco, M. R. (1994) · JAMA · doi:10.1001/jama.1994.03510440053032 · Cited by 497
Janicke, F., Prechtl, A., Thomssen, C., Harbeck, N., Meisner, C., Untch, M., Sweep, C. G. J. F., Selbmann, H.-K., Graeff, H., & Schmitt, M. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.12.913 · Cited by 434
Recent Trends in U.S. Breast Cancer Incidence, Survival, and Mortality Rates
Chu, K. C., Tarone, R. E., Kessler, L. G., Ries, L. A. G., Hankey, B. F., Miller, B. A., & Edwards, B. K. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1571 · Cited by 430
Howell, A., Ribeiro, G. G., & Swindell, R. (1995) · Cited by 410
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2843 · Cited by 353
Evidence of prenatal influences on breast cancer risk
Ekbom, A., Adami, H.-O., Trichopoulos, D., Hsieh, C.-C., & Lan, S.-J. (1992) · The Lancet · doi:10.1016/0140-6736(92)93019-j · Cited by 347
Elledge, R. M., Green, S., Pugh, R., Allred, D. C., Clark, G. M., Hill, J., Ravdin, P., Martino, S., & Osborne, C. K. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<111::aid-ijc2>3.0.co;2-w · Cited by 325
Yamauchi, H., Stearns, V., & Hayes, D. F. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2334 · Cited by 291
Mohsin, S. K., Weiss, H., Havighurst, T., Clark, G. M., Berardo, M., Roanh, L. D., To, T. V., Zho, Q., Love, R. R., & Allred, D. C. (2004) · Modern Pathology · doi:10.1038/modpathol.3800229 · Cited by 290
Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials
SLAMON, D. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90188-5 · Cited by 243
Barnes, D., Harris, W., Smith, P., Millis, R., & Rubens, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.563 · Cited by 241
Duffy, M. J. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1194 · Cited by 229
Self-citationProgesterone receptors in reproduction: functional impact of the A and B isoforms
Conneely, O. (2000) · Steroids · doi:10.1016/s0039-128x(00)00115-x · Cited by 227
Weihua, Z., Andersson, S., Cheng, G., Simpson, E. R., Warner, M., & Gustafsson, J.-Å. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00436-8 · Cited by 220
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
Ebeling, F. G., Stieber, P., Untch, M., Nagel, D., Konecny, G. E., Schmitt, U. M., Fateh-Moghadam, A., & Seidel, D. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600248 · Cited by 215
Self-citationPrice, M. R., Rye, P. D., Petrakou, E., Murray, A., Brady, K., Imai, S., Haga, S., Kiyozuka, Y., Schol, D., Meulenbroek, M. F. A., et al. (1998) · Tumor Biology · doi:10.1159/000056500 · Cited by 213
Family History, Age, and Risk of Breast Cancer: Prospective Data From the Nurses' Health Study
Colditz, G. A. (1993) · JAMA · doi:10.1001/jama.1993.03510030062035 · Cited by 211
The development and clinical use of trastuzumab (Herceptin).
Harries, M., & Smith, I. (2002) · Endocrine-related cancer · doi:10.1677/erc.0.0090075 · Cited by 196
Immunohistochemical detection of steroid receptors in breast cancer: a working protocol: Table 1
Leake, R., Barnes, D., Pinder, S., Ellis, I., Anderson, L., Anderson, T., Adamson, R., Rhodes, T., Miller, K., & Walker, R. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.8.634 · Cited by 189
Predictive Markers in Breast and Other Cancers: A Review
Duffy, M. J. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046227 · Cited by 174
Self-citationKoning, H. J. D., Boer, R., Warmerdam, P. G., Beemsterboer, P. M. M., & van, P. J. D. M. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.16.1217 · Cited by 172
Trastuzumab: hopes and realities
Leyland-Jones, B. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00676-9 · Cited by 169
HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications.
Baselga, J. M., Seidman, A. D., Rosen, P. P., & Norton, L. (1997) · PubMed · Cited by 157
HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer
Konecny, G., Thomssen, C., Lück, H., Untch, M., Wang, H.-J., Kuhn, W. C., Eidtmann, H., Bois, A. D., Olbricht, S., Steinfeld, D., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh198 · Cited by 156
Pertschuk, L. P., Feldman, J. G., Kim, Y.-D., Braithwaite, L., Schneider, F., Braverman, A. S., & Axiotis, C. A. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960615)77:12<2514::aid-cncr14>3.0.co;2-v · Cited by 133
Duffy, M. J., Duggan, C. R., Keane, R., Hill, A. D. K., McDermott, E. W. M., Crown, J. P., & O’Higgins, N. J. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.025288 · Cited by 116
Self-citationNew prognostic factors for breast cancer recurrence
Isaacs, C. J., Stearns, V., & Hayes, D. F. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90045-4 · Cited by 108
Kamel, E. M., Wyss, M. T., Fehr, M. K., von Schulthess, G. K., & Goerres, G. W. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0424-z · Cited by 86
Pregnancy Termination in Relation to Risk of Breast Cancer
Newcomb, P. A., Storer, B. E., Longnecker, M. P., Mittendorf, R., Greenberg, E. R., & Willett, W. C. (1996) · JAMA · doi:10.1001/jama.1996.03530280035033 · Cited by 86
Benraad, T. J., Geurts-Moespot, J., Grøndahl-Hansen, J., Schmitt, M., Heuvel, J. J. T. M., Witte, J., Foekens, J. A., Leake, R. E., Brünner, N., & Sweep, F. C. G. J. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00118-9 · Cited by 69
Guidelines on endocrine therapy of breast cancerEUSOMA
Blamey, R. W. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00011-4 · Cited by 61
An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma
O'Hanlon, D. M., Kerin, M. J., Kent, P. J., Maher, D., Grimes, H., & Given, H. F. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.249 · Cited by 55
Piccart, M. J., Leo, A. D., & Hamilton, A. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00162-3 · Cited by 53
Oestrogen and progesterone receptor determinations in breast cancer: technology and biology.
Sm, T., & Rose, C. (1986) · PubMed · Cited by 47
Sjöström, J., Collan, J., von Boguslawski, K., Franssila, K., Bengtsson, N., Mjaaland, I., Malmström, P., Østenstad, B., Wist, E., Valvere, V., et al. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00403-8 · Cited by 41
CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer
Devine, P. L., Duroux, M., Quin, R. J., et al. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00689716 · Cited by 26
Leers, M. P. G., & Nap, M. (2001) · The Breast Journal · doi:10.1046/j.1524-4741.2001.20108.x · Cited by 16
Self-citation
Cited by
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
Self-citationBreast Cancer: Current Perspectives on the Disease Status
Fahad Ullah, M. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-20301-6_4 · Cited by 598
Lindström, L. S., Karlsson, E., Wilking, U. M., Johansson, U., Hartman, J., Lidbrink, E. K., Hatschek, T., Skoog, L., & Bergh, J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.2482 · Cited by 523
Duffy, M. J., Harbeck, N., Nap, M., Molina, R., Nicolini, A., Senkus, E., & Cardoso, F. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.01.017 · Cited by 522
Self-citation
Metadata
- Authors
- Molina, R., Barak, V., van Dalen, A., Duffy, M. J., Einarsson, R., Gion, M., Goike, H., Lamerz, R., Nap, M., Sölétormos, G., & Stieber, P.
- Venue
- Tumor Biology
- Published
- 2005
- Volume
- 26
- Issue
- 6
- Pages
- 281-293
- ISSN
- 1010-4283 (ISSN-L)
- 1423-0380
- OpenAlex
- W1998050847
- Cited by
- 334
- References
- 67
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.